IL6 and COVID-19: It was reported that tenascin-C and fibrinogen-β are highly abundant in circulating small EVs from COVID-19 patients in comparison to healthy controls, and that exposure of human hepatocytes to these EVs triggers proinflammatory cytokines, evidenced by an increased expression of TNF-α, IL-6, and CCL5 [61].